|1.||Gong, Liang: 4 articles (11/2015 - 07/2011)|
|2.||Tang, Chun-Lan: 2 articles (05/2015 - 07/2011)|
|3.||Wang, Hai-Jing: 2 articles (05/2015 - 07/2011)|
|4.||Yang, He-Ping: 2 articles (05/2015 - 07/2011)|
|5.||Lee, Jung Joon: 2 articles (12/2009 - 04/2008)|
|6.||Liu, Philip T: 2 articles (05/2009 - 07/2007)|
|7.||Sayre, James: 2 articles (05/2009 - 07/2007)|
|8.||Fiala, Milan: 2 articles (05/2009 - 07/2007)|
|9.||Mahanian, Michelle: 2 articles (05/2009 - 07/2007)|
|10.||Rosenthal, Mark J: 2 articles (05/2009 - 07/2007)|
|1.||Alzheimer Disease (Alzheimer's Disease)
05/29/2009 - "Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. "
07/31/2007 - "Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin."
02/01/2009 - "Curcuminoids (a mixture of curcumin, bisdemethoxycurcumin and demethoxycurcumin) share vital pharmacological properties possessed by turmeric, a well known curry spice, considered useful in Alzheimer's disease (AD). "
01/01/2015 - "Curcumin (Cur) and bisdemethoxycurcumin (BDMC), extracted from Curcuma longa, are poorly water-soluble polyphenol compounds that have shown anti-inflammatory potential for the treatment of osteoarthritis. "
01/01/2015 - "Evaluation of the protective effects of curcuminoid (curcumin and bisdemethoxycurcumin)-loaded liposomes against bone turnover in a cell-based model of osteoarthritis."
02/15/2014 - "Curcuminoids, a mixture of curcumin, demethoxycurcumin (DMC), and bisdemethoxycurcumin (BDMC), have shown a variety of clinical benefits for several human chronic diseases including osteoarthritis, rheumatoarthritis, and type II diabetes. "
|3.||Stomach Ulcer (Gastric Ulcer)
04/01/2009 - "These results indicated that bisdemethoxycurcumin directly accelerates gastric ulcer healing with potency equal to curcumin. "
04/01/2009 - "Comparative antiulcer effect of bisdemethoxycurcumin and curcumin in a gastric ulcer model system."
04/01/2009 - "The antiulcer effect of bisdemethoxycurcumin, a yellow pigment found mainly in rhizomes of Curcuma longa, was compared with curcumin in gastric ulcer model systems to validate its clinical application as a remedy for peptic ulcer. "
04/01/2009 - "In an animal model, intraduodenal administration of bisdemethoxycurcumin (5-80 mg/kg body wt.) showed a strong inhibitory effect on gastric acid secretion in pylorus-ligated rats whereas curcumin (5-20 mg/kg body wt.) showed a less inhibitory effect, with maximum potency at a dose of 20mg/kg body wt. Moreover, oral administration of bisdemethoxycurcumin at doses of 20-80 mg/kg body wt. twice daily for 10 days showed a significant curative efficacy in accelerating the healing of acetic acid-induced chronic gastric ulcer and promotion of mucosal regeneration in the ulcerated portion in a dose-related manner with potency equal to curcumin. "
|4.||Peptic Ulcer (Peptic Ulcers)
|5.||Body Weight (Weight, Body)
12/01/2013 - "Pretreatment with polymeric N-isopropyl acryl amide (PNIPAM) nanoparticles formulation of all three curcuminoids (curcumin (Cur), demethoxycurcumin (DMC), and bisdemethoxycurcumin (BDMC)) at doses (100 μg/kg body weight) given intranasally was effective in bringing significant changes on all the parameters. "
|2.||Toll-Like Receptors (Toll-Like Receptor)
|10.||Acetic Acid (Vinegar)